248 related articles for article (PubMed ID: 25713168)
1. 15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers.
Leng S; Liu Y; Weissfeld JL; Thomas CL; Han Y; Picchi MA; Edlund CK; Willink RP; Gaither Davis AL; Do KC; Nukui T; Zhang X; Burki EA; Van Den Berg D; Romkes M; Gauderman WJ; Crowell RE; Tesfaigzi Y; Stidley CA; Amos CI; Siegfried JM; Gilliland FD; Belinsky SA
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713168
[TBL] [Abstract][Full Text] [Related]
2. Implication of a Chromosome 15q15.2 Locus in Regulating UBR1 and Predisposing Smokers to MGMT Methylation in Lung.
Leng S; Wu G; Collins LB; Thomas CL; Tellez CS; Jauregui AR; Picchi MA; Zhang X; Juri DE; Desai D; Amin SG; Crowell RE; Stidley CA; Liu Y; Swenberg JA; Lin Y; Wathelet MG; Gilliland FD; Belinsky SA
Cancer Res; 2015 Aug; 75(15):3108-17. PubMed ID: 26183928
[TBL] [Abstract][Full Text] [Related]
3. Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study.
Leng S; Stidley CA; Liu Y; Edlund CK; Willink RP; Han Y; Landi MT; Thun M; Picchi MA; Bruse SE; Crowell RE; Van Den Berg D; Caporaso NE; Amos CI; Siegfried JM; Tesfaigzi Y; Gilliland FD; Belinsky SA
Cancer Res; 2012 Feb; 72(3):707-15. PubMed ID: 22139380
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
5. Dietary Nutrient Intake, Ethnicity, and Epigenetic Silencing of Lung Cancer Genes Detected in Sputum in New Mexican Smokers.
Leng S; Picchi MA; Kang H; Wu G; Filipczak PT; Juri DE; Zhang X; Gauderman WJ; Gilliland FD; Belinsky SA
Cancer Prev Res (Phila); 2018 Feb; 11(2):93-102. PubMed ID: 29118161
[TBL] [Abstract][Full Text] [Related]
6. Gene Promoter Hypermethylation Detected in Sputum Predicts FEV
Leng S; Diergaarde B; Picchi MA; Wilson DO; Gilliland FD; Yuan JM; Siegfried JM; Belinsky SA
Am J Respir Crit Care Med; 2018 Jul; 198(2):187-196. PubMed ID: 29437466
[TBL] [Abstract][Full Text] [Related]
7. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
[TBL] [Abstract][Full Text] [Related]
8. Gene promoter methylation in plasma and sputum increases with lung cancer risk.
Belinsky SA; Klinge DM; Dekker JD; Smith MW; Bocklage TJ; Gilliland FD; Crowell RE; Karp DD; Stidley CA; Picchi MA
Clin Cancer Res; 2005 Sep; 11(18):6505-11. PubMed ID: 16166426
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
[TBL] [Abstract][Full Text] [Related]
10. Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers.
Danoy P; Michiels S; Dessen P; Pignat C; Boulet T; Monet M; Bouchardy C; Lathrop M; Sarasin A; Benhamou S
Int J Cancer; 2008 Jul; 123(2):457-463. PubMed ID: 18449888
[TBL] [Abstract][Full Text] [Related]
11. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
[TBL] [Abstract][Full Text] [Related]
12. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
[TBL] [Abstract][Full Text] [Related]
13. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
[TBL] [Abstract][Full Text] [Related]
14. Targeted sequencing of chromosome 15q25 identified novel variants associated with risk of lung cancer and smoking behavior in Chinese.
Cheng Y; Wang C; Zhu M; Dai J; Wang Y; Geng L; Li Z; Zhang J; Ma H; Jin G; Lin D; Hu Z; Shen H
Carcinogenesis; 2017 May; 38(5):552-558. PubMed ID: 28369244
[TBL] [Abstract][Full Text] [Related]
15. DNMT3B polymorphisms and risk of primary lung cancer.
Lee SJ; Jeon HS; Jang JS; Park SH; Lee GY; Lee BH; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Cho YL; Jung TH; Park JY
Carcinogenesis; 2005 Feb; 26(2):403-9. PubMed ID: 15528220
[TBL] [Abstract][Full Text] [Related]
16. [Cyclooxygenase 2 genetic variant interacting with tobacco smoking and the risk of lung cancer].
Zhang Z; Liu R; Yang ZH; Wang GX; Shao SS; Song QQ; Zhang XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):736-40. PubMed ID: 24246081
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum.
Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA
Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078
[TBL] [Abstract][Full Text] [Related]
19. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
[TBL] [Abstract][Full Text] [Related]
20. Defining a gene promoter methylation signature in sputum for lung cancer risk assessment.
Leng S; Do K; Yingling CM; Picchi MA; Wolf HJ; Kennedy TC; Feser WJ; Baron AE; Franklin WA; Brock MV; Herman JG; Baylin SB; Byers T; Stidley CA; Belinsky SA
Clin Cancer Res; 2012 Jun; 18(12):3387-95. PubMed ID: 22510351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
